Presenter(s): Brian Hurley, M.D., M.B.A., DFASAM, FAPA 

Target Audience: This activity is designed for Nurses, MAT Team Providers, Addictions Specialists, SUD Project Directors, Managers, and Facilitators.  

Webinar Description: This webinar will review variations on buprenorphine dosing that can be considered for patients with opioid use disorder involving fentanyl. The presenters will review the evidence for and describe low dose buprenorphine initiation of protocols, high dose buprenorphine initiation of protocols, approaches to help support patients stop using full agonist opioids for a longer period of time, and a clinical approach to referring patients to alternative medications for opioid use disorder. 

Educational Objectives:

• Compare and contrast low-dose, high-dose, standard dose, and variations for the timing and setting for initiating buprenorphine to treat opioid use disorder involving fentanyl.
• Design a treatment plan that factors in the risks and benefits of buprenorphine to treat opioid use disorder in consideration of the set, setting, and patient’s priorities for their opioid use disorder treatment.
• Recognize the limitations of buprenorphine treatment of opioid use disorder and how to refer to alternative treatments.

Requirements for successful activity completion:

In order to successfully complete this activity and obtain your Certificate, you will be required to:

1. Course Content: Complete the pre-reflection question and view the recorded presentation.
   
   
2. Click Survey and answer the questions to the best of your ability.
   Upon completion of this survey, it will unlock and allow you to proceed to the final course evaluation. 
   
   
3. Click Evaluation to complete the final PCSS course evaluation.
   
   

4. Following your completion of the evaluation, you will have access to your Certificate of Completion.